Predicted to enable transcription cis-regulatory region binding activity and transcription coactivator activity. Predicted to be involved in adipose tissue development and negative regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including cellular response to leukemia inhibitory factor; face morphogenesis; and gonad development. Predicted to be active in nucleus. Orthologous to human ARID5B (AT-rich interaction domain 5B).
RGD Description
Predicted to enable transcription cis-regulatory region binding activity and transcription coactivator activity. Predicted to be involved in adipose tissue development and negative regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including cellular response to leukemia inhibitory factor; face morphogenesis; and gonad development. Predicted to be located in nucleus. Orthologous to human ARID5B (AT-rich interaction domain 5B); INTERACTS WITH 17beta-estradiol; 2,2',5,5'-tetrachlorobiphenyl; bisphenol A.